New research published in Neurology links high consumption of low-calorie sweeteners to faster cognitive decline, particularly in adults under 60 and people with diabetes.
New research from Rutgers University identifies a small increase in the risk of ischemic optic neuropathy among patients taking GLP-1 medications like Ozempic and Wegovy.
A comprehensive review reveals how immune cells like macrophages and neutrophils fail to transition from inflammation to repair, stalling diabetic wound healing.
